Kliniske undersøgelser viser, at behandlingen forløber godt hos de fleste patienter, hvis tacrolimus´ blodkoncentrationer holdes under 20 ng/ ml.
Clinical study analysis suggests that the majority of patients can be successfully managed if tacrolimus blood trough levels are maintained below 20 ng/ ml.